"Real-Time" High-Throughput Drug and Synergy Testing for Multidrug-Resistant Bacterial Infection: A Case Report

about

"Real-Time" High-Throughput Drug and Synergy Testing for Multidrug-Resistant Bacterial Infection: A Case Report

Item

http://www.wikidata.org/entity/Q57300149

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

"Real-Time" High-Throughput Dr ...... erial Infection: A Case Report

@en

"Real-Time" High-Throughput Dr ...... erial Infection: A Case Report

@nl

type

Item

label

"Real-Time" High-Throughput Dr ...... erial Infection: A Case Report

@en

"Real-Time" High-Throughput Dr ...... erial Infection: A Case Report

@nl

prefLabel

"Real-Time" High-Throughput Dr ...... erial Infection: A Case Report

@en

"Real-Time" High-Throughput Dr ...... erial Infection: A Case Report

@nl

P1476

"Real-Time" High-Throughput Dr ...... erial Infection: A Case Report

@en

P2093

Miao Xu

http://www.w3.org/2001/XMLSchema#string

Peter R Williamson

http://www.w3.org/2001/XMLSchema#string

Richard W Childs

http://www.w3.org/2001/XMLSchema#string

Shayla Hesse

http://www.w3.org/2001/XMLSchema#string

Wei Sun

http://www.w3.org/2001/XMLSchema#string

Wei Zheng

http://www.w3.org/2001/XMLSchema#string

P2860

Adverse events associated with meropenem versus imipenem/cilastatin therapy in a large retrospective cohort of hospitalized infants

Combination approaches to combat multidrug-resistant bacteria.

When does 2 plus 2 equal 5? A review of antimicrobial synergy testing.

Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis.

Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens

Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol

Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria.

Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.

Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial.

Evaluation of colistin stability in agar and comparison of four methods for MIC testing of colistin.

P304

267

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.3389/FMED.2018.00267

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30298132

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

P932

6160733

http://www.w3.org/2001/XMLSchema#string